COVID-19 Therapeutics for Nonhospitalized Patients—Updates and Future Directions | Clinical Pharmacy and Pharmacology | JAMA

In this Viewpoint, the authors summarize the therapeutic landscape for COVID-19, discuss who is most likely to benefit from treatment, provide an update on mana

Related Keywords

Massachusetts ,United States ,Boston ,America ,Pardes Biosciences ,Rajesht Gandhi ,Infectious Diseases Society Of America ,National Institutes Of Health ,University Of Liverpool ,Drug Administration ,Treatment Guidelines Panel ,Emergency Use Authorization ,National Institutes ,Patients Who Are ,Massachusetts General Hospital ,Interest Disclosures ,Merck Sharp ,Guidelines Panel ,Infectious Diseases Society ,